GLP-1 agonists reduce appetite, modulate satiety circuits, alter hepatic lipid handling, improve endothelial function, attenuate inflammatory tone, influence microglial behavior, and appear to exert downstream neuroprotective effects, yet the field cannot convincingly articulate how these effects relate to one another, which are primary versus secondary, or which are merely correlative epiphenomena arising from broader systemic shifts
Peak Wellness is built for speed and simplicity, using a structured intake instead of live appointments
Ipamorelin, if properly dosed, seems to have negligible side effects
Safe for multi-dose vials
Dose-Dependent Pricing Structure Current market data indicates pricing correlates directly with medication strength and quantity per prescription
3 and Supplementary Fig